AMAR - Amarillo Biosciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
22.855
11.731
77.724
250.928
0
Cost of Revenue
16.86
8.772
64.877
60.316
0
Gross Profit
5.995
2.959
12.847
190.612
0
Operating Expense
1,572
1,583
1,348
770.375
667.111
Operating Income
-1,566
-1,580
-1,335
-579.763
-667.111
Net Non Operating Interest Income Expense
-1.005
-0.885
-3.963
-37.612
-2.871
Pretax Income
-1,567
-1,581
-1,339
-617.375
-669.982
Net Income Common Stockholders
-1,567
-1,581
-1,339
-617.375
-669.982
Diluted NI Available to Com Stockholders
-1,567
-1,581
-1,339
-617.375
-669.982
Basic EPS
-
-
0
0
0
Diluted EPS
-
-
0
0
0
Basic Average Shares
-
-
35,644
22,663
21,056
Diluted Average Shares
-
-
35,644
22,663
21,056
Total Operating Income as Reported
-1,566
-1,580
-1,335
-579.763
-667.111
Total Expenses
1,589
1,592
1,412
830.691
667.111
Net Income from Continuing & Discontinued Operation
-1,567
-1,581
-1,339
-617.375
-669.982
Normalized Income
-1,567
-1,581
-1,339
-617.375
-669.982
Interest Expense
-
-
3.963
37.612
2.871
Net Interest Income
-1.005
-0.885
-3.963
-37.612
-2.871
EBIT
-1,566
-1,580
-1,335
-579.763
-667.111
EBITDA
-1,566
-
-
-
-
Reconciled Cost of Revenue
16.86
8.772
64.877
60.316
0
Reconciled Depreciation
-
22.241
56.194
39.99
25.956
Net Income from Continuing Operation Net Minority Interest
-1,567
-1,581
-1,339
-617.375
-669.982
Normalized EBITDA
-1,566
-1,558
-1,278
-539.773
-641.155
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0